Clinical trials
Phase 2 Scleroderma, Systemic trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 8 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ISDIN | 2 |
| Lakefront Biotherapeutics NV | 2 |
| Sanofi | 2 |
| United Therapeutics | 2 |
| University College, London | 2 |
| Actelion | 1 |
| Amgen | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 27 |
| Scleroderma, Diffuse | 7 |
| Raynaud Disease | 5 |
| Lung Diseases, Interstitial | 3 |
| Scleroderma, Limited | 2 |
| Autoimmune Diseases | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Fatigue | 1 |
| Fibrosis | 1 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.